"Ergofarma", UAB Finance - revenue, profit
EBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo data| Indicator |
|---|
| Turnover (€) |
| Sales per employee (€) |
| Profit before tax (€) |
| Net Profit (€) |
| Profit per employee (€) |
| Total profitability (%) |
| Net profitability (%) |
| Equity (€) |
| Amounts Payable And Liabilities (€) |
| Non-current Assets (€) |
| CurrentAssets (€) |
| Working capital requirement |
| Debt-to-equity ratio |
| EBITDA margin (%) |
| EBITDA (€) |
| EBIT margin (%) |
| EBIT (€) |
| 2023 |
|---|
| 14,693 |
| 14,693 |
| 4,846 |
| -4,846 |
| -4,846 |
| -26.58 |
| -32.98 |
| 5,986 |
| 9,678 |
| 0 |
| 15,652 |
| 0.41 |
| 1.62 |
| - |
| - |
| -26.58 |
| -3,906 |
| 2024 |
|---|
| 9,507 |
| 9,507 |
| 7,905 |
| -7,905 |
| -7,905 |
| -68.94 |
| -83.15 |
| -1,919 |
| 12,935 |
| 0 |
| 11,016 |
| -0.20 |
| -6.74 |
| - |
| - |
| -68.94 |
| -6,554 |
| 2025 |
|---|
| 376 |
| 376 |
| 27,393 |
| -27,393 |
| -27,393 |
| -6,539.36 |
| -7,285.37 |
| -29,313 |
| 38,141 |
| 0 |
| 8,828 |
| -77.96 |
| -1.30 |
| - |
| - |
| -6,539.36 |
| -24,588 |
| 2025 |
|---|
| 376 |
| 376 |
| 27,393 |
| -27,393 |
| -27,393 |
| -6,539.36 |
| -7,285.37 |
| -29,313 |
| 38,141 |
| 0 |
| 8,828 |
| -77.96 |
| -1.30 |
| - |
| - |
| -6,539.36 |
| -24,588 |
Turnover (€)
2025
Turnover (€)
376 €-96 % *
Sales per employee (€)
376 €-96 % *
Profit before tax (€)
27,393 €247 % *
Net Profit (€)
-27,393 €-247 % *
Profit per employee (€)
-27,393 €-247 % *
Total profitability (%)
-6,539.36 %-9,385.58 % *
Net profitability (%)
-7,285.37 %-8,661.72 % *
Equity (€)
-29,313 €-1,428 % *
Amounts Payable And Liabilities (€)
38,141 €195 % *
Non-current Assets (€)
0 €- *
CurrentAssets (€)
8,828 €-20 % *
Working capital requirement
-77.96 -38,880.00 % *
Debt-to-equity ratio
-1.30 80.71 % *
EBITDA margin (%)
-EBITDA (€)
-EBIT margin (%)
-6,539.36 %-9,385.58 % *
EBIT (€)
-24,588 €-275 % *
